Welcome to Medications.com
GSK cuts abacavir price by 31% for developing countries - Aidsmap
The World Health Organization’s expert advisers concluded that developing countries should focus on the protease inhibitors lopinavir/ritonavir (Kaletra) ...
http://www.aidsmap.com/en/news/A2... |
Posted: Wed Feb 20 08:00:26 -0500 2008
Kaletra RSS Feed
© 2002-2007, Skylabs Inc. |
About Us |
Disclaimer/Terms of Use |
Advertise |
Contact Us |
Site Map |
Developed by:
W3matter.com |
Sleep Apnea
